These results at the whole-genome level expand a previous observation in glioma, where the methylation status of PDGFB predisposes tumor cells for either an oncogenic or a tumor-suppressive response to TGF-β signaling (Bruna et al., 2007). The gene discussed is PDGFB; the disease is central nervous system cancer.